Literature DB >> 7166179

Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates.

R G Khalifah, C E Hignite, P J Pentikäinen, A Penttilä, P J Neuvonen.   

Abstract

Metabolites of tolfenamic acid appearing in human urine have been isolated and their structures determined by C-13 nuclear magnetic resonance and gas chromatography-mass spectrometry. Comparative studies on tolfenamic, mefenamic, and flufenamic acids in conjunction with the metabolites have permitted complete C-13 NMR assignments for this series of compounds. Five metabolites identified included three that were monohydroxylated, one that was both methoxylated and hydroxylated, and another in which the methyl group was oxidized to a carboxyl group. The information presented on the fenamate standards and the metabolites represents an excellent basis for structural elucidation of other fenamates and their metabolites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7166179     DOI: 10.1007/BF03189629

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  5 in total

1.  Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent.

Authors:  P J Pentikäinen; P J Neuvonen; C Backman
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

2.  Prolonged treatment with tolfenamic acid in inflammatory rheumatic diseases.

Authors:  A Kajander; J Martio; O Mutru; G Gothoni
Journal:  Scand J Rheumatol       Date:  1976       Impact factor: 3.641

3.  Inhibition of prostaglandin biosynthesis by tolfenamic acid in vitro.

Authors:  I B Lindén; J Parantainen; H Vapaatalo
Journal:  Scand J Rheumatol       Date:  1976       Impact factor: 3.641

4.  A comparative, double-blind study on tolfenamic acid in the treatment of rheumatoid arthritis.

Authors:  V Rejholec; H Vapaatalo; O Tokola; G Gothoni
Journal:  Scand J Rheumatol Suppl       Date:  1979

5.  Tolfenamic acid is as effective as ergotamine during migraine attacks.

Authors:  H Hakkarainen; H Vapaatalo; G Gothoni; J Parantainen
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

  5 in total
  3 in total

1.  Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver.

Authors:  J Stenderup; J Eriksen; S B Pedersen; L V Christiansen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Pharmacokinetics of tolfenamic acid: disposition in bile, blood and urine after intravenous administration to man.

Authors:  P J Pentikäinen; O Tokola; E Alhava; A Penttilä
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Protein binding of tolfenamic acid in the plasma from patients with renal and hepatic disease.

Authors:  M Láznícek; K E Senius
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.